New technologies for the detection of circulating tumour cells
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The vast majority of cancer-related death is due to the metastatic spread of the primary tumour. Circulating tumour cells (CTC) are essential for establishing metastasis and their detection has long been considered as a possible tool to assess the aggressiveness of a given tumour and its potential of subsequent growth at distant organs. Conventional markers are not reliable in detecting occult metastasis and, for example, fail to identify approximately 40% of cancer patients in need of more aggressive or better adjusted therapies. Recent studies in metastatic breast cancer have shown that CTC detection can be used as a marker for overall survival and assessment of the therapeutic response. The benefits of CTC detection in early breast cancer and other solid tumours need further validation. Moreover, optimal CTC detection techniques are the subject of controversy as several lack reproducibility, sensitivity and/or specificity. Recent technical advances allow CTC detection and characterization at the single-cell level in the blood or in the bone marrow. Their reproducibility propels the use of CTC in cancer staging and real-time monitoring of systemic anticancer therapies in several large clinical trials. CTC assays are being integrated in large clinical trials to establish their potential in the management of cancer patients and improve our understanding of metastasis biology. This review will focus on the techniques currently used, the technical advancements made, the limitations of CTC detection and future perspectives in this field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686
Cited by
Bhagat, A. A. S., Hou, H. W., Li, L. D., Lim, C. T., & Han, J. (2011) · Lab on a Chip · doi:10.1039/c0lc00633e · Cited by 350
Microfluidic platform for negative enrichment of circulating tumor cells
Sajay, B. N. G., Chang, C.-P., Ahmad, H., Khuntontong, P., Wong, C. C., Wang, Z., Puiu, P. D., Soo, R., & Rahman, A. R. A. (2014) · Biomedical Microdevices · doi:10.1007/s10544-014-9856-2 · Cited by 56
“Current technologies for CTC isolation have been well-reviewed (Arya et al. 2013; Chen et al. 2012; Zhe et al. 2011; Yu et al. 2011; Sun et al. 2011; Gerges et al. 2010; Hou et al. 2010).”
BackgroundIsolation of circulating tumour cells by physical means in a microfluidic device: a review
Patil, P., Madhuprasad, M., Kumeria, T., Losic, D., & Kurkuri, M. (2015) · RSC Advances · doi:10.1039/c5ra16489c · Cited by 47
Micro/nanofluidic technologies for efficient isolation and detection of circulating tumor cells
Yue, W.-Q., Tan, Z., Li, X.-P., Liu, F.-F., & Wang, C. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.06.009 · Cited by 34
Metadata
- Authors
- Gerges, N., Rak, J., & Jabado, N.
- Venue
- British Medical Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-04-23
- Volume
- 94
- Issue
- 1
- Pages
- 49-64
- ISSN
- 0007-1420 (ISSN-L)
- 1471-8391
- OpenAlex
- W2147447988
- Cited by
- 114
- References
- 1
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New technologies for the detection of circulating tumour cells. https://app.cochat.ai/papers/10.1093/bmb/ldq011
- The paper
- Gerges, N., Rak, J., & Jabado, N. (2010). New technologies for the detection of circulating tumour cells. British Medical Bulletin. https://doi.org/10.1093/bmb/ldq011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.